Average Co-Inventor Count = 6.39
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eli Lilly and Company (9 from 4,442 patents)
2. Bayer Pharmaceuticals Corporation (2 from 70 patents)
11 patents:
1. 11028074 - CD73 inhibitors
2. 9776992 - 1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors in the treatment of cancers
3. 9156824 - CDC7 inhibitors
4. 8217032 - Selective estrogen receptor modulators for the treatment of vasomotor symptoms
5. 8148387 - AKT and P70 S6 kinase inhibitors
6. 7863310 - Kinase inhibitors
7. 7745438 - 3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use as bace inhibitors
8. 7585977 - Selective estrogen receptor modulators containing a phenylsulfonyl group
9. 7320995 - Benzimidazoles and benzothiazoles as inhibitors of map kinase
10. 6919371 - 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
11. 6660752 - 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists